INDIVIDUAL-DIFFERENCES IN THE ORIENTATION OF THE CYTOLYTIC T-CELL RESPONSE AGAINST MOUSE-TUMOR P815

被引:54
作者
BRICHARD, VG
WARNIER, G
VANPEL, A
MORLIGHEM, G
LUCAS, S
BOON, T
机构
[1] LUDWIG INST CANC RES,BRUSSELS BRANCH,UCL 7459,B-1200 BRUSSELS,BELGIUM
[2] UNIV CATHOLIQUE LOUVAIN,CELL GENET UNIT,B-1200 BRUSSELS,BELGIUM
关键词
P815; TUMOR ANTIGEN; CYTOLYTIC T LYMPHOCYTES;
D O I
10.1002/eji.1830250306
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We reported previously that the mouse tumor P815 expresses four distinct antigens (A, B, C, D) recognized by syngeneic cytolytic T lymphocytes (CTL). A fifth P815 antigen (E) was identified by means of a CTL done derived from tumor-infiltrating lymphocytes. We compared a number of mice for the orientation of their CTL response with respect to the various P815 antigens. Lymphocytes from mice inoculated subcutaneously with living P815 cells were stimulated in vitro with tumor cells and the resulting CTL were tested against targets expressing either antigens A and B or antigens C, D and E. Many mice had an asymmetrical response, some producing CTL directed almost exclusively against antigens A, B and others producing CTL directed almost exclusively against C, D. E. When mice were inoculated into two separate sites, different orientations in the responses of the two local lymph nodes were often observed, suggesting that individual differences in the orientation of the anti-P815 CTL response do not result from preexisting differences between the animals. Asymmetrical CTL responses persisted in mice that were given a second injection of tumor cells. A possible interpretation of our results is that the major component of the CTL response is made of the progeny of a very small number of CTL precursors that happen to be the first to be stimulated by the tumor antigens.
引用
收藏
页码:664 / 671
页数:8
相关论文
共 25 条
[11]   NAIVE AND MEMORY T-CELLS SHOW DISTINCT PATHWAYS OF LYMPHOCYTE RECIRCULATION [J].
MACKAY, CR ;
MARSTON, WL ;
DUDLER, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (03) :801-817
[12]   IMMUNOGENIC VARIANTS OBTAINED BY MUTAGENESIS OF MOUSE MASTOCYTOMA P815 .4. ANALYSIS OF VARIANT-SPECIFIC ANTIGENS BY SELECTION OF ANTIGEN-LOSS VARIANTS WITH CYTOLYTIC T-CELL CLONES [J].
MARYANSKI, JL ;
BOON, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1982, 12 (05) :406-412
[13]   LIFE-SPAN OF HUMAN LYMPHOCYTE SUBSETS DEFINED BY CD45 ISOFORMS [J].
MICHIE, CA ;
MCLEAN, A ;
ALCOCK, C ;
BEVERLEY, PCL .
NATURE, 1992, 360 (6401) :264-265
[14]   THE SIZES OF THE CDR3 HYPERVARIABLE REGIONS OF THE MURINE T-CELL RECEPTOR BETA-CHAINS VARY AS A FUNCTION OF THE RECOMBINED GERM-LINE SEGMENTS [J].
PANNETIER, C ;
COCHET, M ;
DARCHE, S ;
CASROUGE, A ;
ZOLLER, M ;
KOURILSKY, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (09) :4319-4323
[15]   T-CELL RECEPTOR (TCR) STRUCTURE OF AUTOLOGOUS MELANOMA REACTIVE CYTOTOXIC T-LYMPHOCYTE (CTL) CLONES - TUMOR-INFILTRATING LYMPHOCYTES OVEREXPRESS IN-VIVO THE TCR BETA-CHAIN SEQUENCE USED BY AN HLA-A2-RESTRICTED AND MELANOCYTE-LINEAGE SPECIFIC CTL CLONE [J].
SENSI, M ;
SALVI, S ;
CASTELLI, C ;
MACCALLI, C ;
MAZZOCCHI, A ;
MORTARINI, R ;
NICOLINI, G ;
HERLYN, M ;
PARMIANI, G ;
ANICHINI, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (04) :1231-1246
[16]  
SUZUKI M, 1992, J IMMUNOL, V148, P2968
[17]   TURNOVER OF NAIVE-PHENOTYPE AND MEMORY-PHENOTYPE T-CELLS [J].
TOUGH, DF ;
SPRENT, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) :1127-1135
[18]   ESCAPE OF MOUSE MASTOCYTOMA P815 AFTER NEARLY COMPLETE REJECTION IS DUE TO ANTIGEN-LOSS VARIANTS RATHER THAN IMMUNOSUPPRESSION [J].
UYTTENHOVE, C ;
MARYANSKI, J ;
BOON, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 157 (03) :1040-1052
[19]   IMMUNOGENIC VARIANTS OBTAINED BY MUTAGENESIS OF MOUSE MASTOCYTOMA P815 .1. REJECTION BY SYNGENEIC MICE [J].
UYTTENHOVE, C ;
VANSNICK, J ;
BOON, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 152 (05) :1175-1183
[20]   THE GENE CODING FOR A MAJOR TUMOR REJECTION ANTIGEN OF TUMOR P815 IS IDENTICAL TO THE NORMAL GENE OF SYNGENEIC DBA-2 MICE [J].
VANDENEYNDE, B ;
LETHE, B ;
VANPEL, A ;
DEPLAEN, E ;
BOON, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (06) :1373-1384